| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |